## Abstract The progression of experimental spinal cord injury (SCI) was followed with in vivo dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) and neurobehavioral studies on postinjury days 0, 2, 4, 7, 10, 14, 17, 21, 28, 35, and 42. Gadopentate dimeglumine (Gd) was administered IV a
Blood–spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced MRI
✍ Scribed by David M. Cohen; Chirag B. Patel; Pallavi Ahobila-Vajjula; Laura M. Sundberg; Tessy Chacko; Shi-Jie Liu; Ponnada A. Narayana
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 293 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0952-3480
- DOI
- 10.1002/nbm.1343
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract A multicompartment pharmacokinetic model was proposed to quantitatively describe the distribution of the contrast agent gadopentetate‐dimeglumine (Gd) in an experimental spinal cord injury (SCI). Concentration of Gd was measured in different compartments with in vivo dynamic contrast‐en
## Abstract Aquaporin 4(AQP4) is a water channel protein strongly expressed in the central nervous system in perimicrovessel astrocyte foot processes, the glia limitans, and ependyma. Expression of AQP4 is highest at the blood‐brain barrier and blood‐spinal cord barrier, supporting its critical fun
Longitudinal in vivo magnetic resonance imaging (MRI) of moderately injured rat spinal cord was performed to investigate the transient loss in gray matter (GM) and white matter (WM) contrast. In addition, neurobehavioral scores (based on open field walking, inclined plane test, and grid walking) and
## Abstract Breakdown of the blood‐brain barrier (BBB), occurring in many neurological diseases, has been difficult to measure noninvasively in humans. Dynamic contrast‐enhanced magnetic resonance imaging measures BBB permeability. However, important technical challenges remain and normative data f